Global Biologics Cell & Gene Legal Summit

The Global Biologics, Cell and Gene Summit is returning for another year to address these changes within the biologics industry with a plethora of biologic patents losing exclusivity within 2023 and an increase in competition with new gene therapy and antibody drug conjugate options emerging and taking the place of “naked antibodies”.

J A Kemp Partner, Jimmy Nicholls will be leading the session on: Antibody Products - A review of European and US Commercialisation, on day 1 of the conference.

Location

Brussels, Belgium

Registration

To book please visit the registration page.